Compass Therapeutics, Inc. (CMPX) Misses Q1 EPS by 1c

Compass Therapeutics, Inc. (NASDAQ: CMPX) reported Q1 EPS of ($0.12), $0.01 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Compass Therapeutics, Inc. (CMPX) click here.

You May Also Be Interested In

• Apple suing OpenAI over alleged misappropriation of trade secrets
• Morgan Stanley Downgrades Cosmos Pharmaceuticals Corp. (3349:JP) (CSMYF) to Equalweight
• L&T Financial Holdings (LTFH:IN) PT Raised to INR380 at Axis Capital Limited